Novartis India Reaches All-Time High, Outperforms Sector and Sensex

Feb 19 2024 09:30 AM IST
share
Share Via
Novartis India, a smallcap pharmaceutical company, has reached an all-time high price on February 19, 2024. The stock has shown strong performance, outperforming the sector by 7.26% and consistently gaining for the past 5 days. It is currently trading above its moving averages and offers a high dividend yield of 4.59%. With a remarkable 1-year performance of 86.99%, Novartis India has shown strong growth potential in the pharma industry.

Novartis India, a smallcap pharmaceutical company, has reached an all-time high price on February 19, 2024. According to MarketsMOJO, the stock is currently rated as 'Hold' and has been a part of the Hidden Turnaround list since January 25, 2024.

The stock has shown strong performance today, outperforming the sector by 7.26%. It has also been on a consecutive gain streak for the past 5 days, with a 25.04% increase in returns during this period. Additionally, the stock opened with a significant gain of 7.58% and touched an intraday high of Rs 1113.9.

Novartis India is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance. At the current price, the stock also offers a high dividend yield of 4.59%.

In comparison to the Sensex, Novartis India has shown a remarkable 1-year performance of 86.99%, while the Sensex has only grown by 18.79%. This highlights the strong growth potential of the company in the pharma industry.

Novartis India's success can be attributed to its consistent performance and strong financials. As a smallcap company, it has shown impressive growth and has the potential to continue its upward trajectory in the future. Investors should keep an eye on this stock as it continues to make strides in the pharma sector.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Novartis India falling/rising?
Dec 05 2025 12:56 AM IST
share
Share Via
Why is Novartis India falling/rising?
Nov 06 2025 10:05 PM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 05 2025 08:06 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 03 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 02 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 01 2025 08:05 AM IST
share
Share Via